Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0, while the study record page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T15:47:59.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A sitewide notice announces an NIH website transition and says both “Super Intelligence” and “Artificial Intelligence” may appear during the change.
    Difference
    1%
    Check dated 2026-10-21T21:53:48.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2; the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T22:06:45.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T22:11:50.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the site header, replacing the previously visible study details and links. This indicates the study record is currently inaccessible.
    Difference
    21%
    Check dated 2026-09-30T22:28:31.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a Home link, indicating the study record is not accessible. The surrounding navigation and header remain, but detailed study content is not visible.
    Difference
    21%
    Check dated 2026-09-23T21:50:44.000Z thumbnail image

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.